当前位置:首页 - 行情中心 - 颖泰生物(920819) - 财务分析 - 现金流量表

颖泰生物

(920819)

  

流通市值:32.35亿  总市值:32.73亿
流通股本:12.12亿   总股本:12.26亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,923,148,721.461,902,753,940.321,077,683,127.314,079,930,922.79
  收到的税费返还204,540,287.36131,895,254.8359,718,961.7258,554,565.75
  收到其他与经营活动有关的现金64,311,403.3561,933,869.1258,907,459.59102,359,785.76
  经营活动现金流入小计3,192,000,412.172,096,583,064.271,196,309,548.64,440,845,274.3
  购买商品、接受劳务支付的现金2,039,972,121.341,410,934,705.28798,256,916.372,770,561,616.04
  支付给职工以及为职工支付的现金468,897,876.42342,450,935.94196,543,959.38657,950,188.96
  支付的各项税费104,106,324.6982,532,932.0144,124,419.01141,705,637.09
  支付其他与经营活动有关的现金135,500,972.6489,498,652.7754,369,575.23271,639,383.01
  经营活动现金流出小计2,748,477,295.091,925,417,2261,093,294,869.993,841,856,825.1
  经营活动产生的现金流量净额443,523,117.08171,165,838.27103,014,678.61598,988,449.2
二、投资活动产生的现金流量:
  收回投资收到的现金109,249,000107,328,00064,832,000115,580,000
  取得投资收益收到的现金22,205,661.217,115,680.665,508,144.1835,541,595.36
  处置固定资产、无形资产和其他长期资产收回的现金净额2,144,254.06551,605.22111,078.2225,025,006.84
  投资活动现金流入小计133,598,915.26124,995,285.8870,451,222.4176,146,602.2
  购建固定资产、无形资产和其他长期资产支付的现金95,605,000.5776,482,699.454,503,775.93163,529,075.74
  投资支付的现金---99,000,000
  支付其他与投资活动有关的现金---282,450
  投资活动现金流出小计95,605,000.5776,482,699.454,503,775.93262,811,525.74
  投资活动产生的现金流量净额37,993,914.6948,512,586.4815,947,446.47-86,664,923.54
三、筹资活动产生的现金流量:
  取得借款收到的现金2,658,327,096.931,508,304,375.41718,042,578.884,660,729,985.44
  收到其他与筹资活动有关的现金15,350,989.059,063,200.910,287,208.9418,595,234.63
  筹资活动现金流入小计2,673,678,085.981,517,367,576.31728,329,787.824,679,325,220.07
  偿还债务支付的现金3,076,990,512.171,665,166,004.17798,071,571.234,823,832,428.37
  分配股利、利润或偿付利息支付的现金112,920,875.5377,516,182.2236,842,438.78175,736,115.5
  其中:子公司支付给少数股东的股利、利润7,200,0007,200,000-3,780,000
  支付其他与筹资活动有关的现金28,271,572.3222,934,856.085,879,492.04105,661,543.87
  筹资活动现金流出小计3,218,182,960.021,765,617,042.47840,793,502.055,105,230,087.74
  筹资活动产生的现金流量净额-544,504,874.04-248,249,466.16-112,463,714.23-425,904,867.67
四、汇率变动对现金及现金等价物的影响-19,383,767.82-11,018,685.01-5,104,944.286,196,484.86
五、现金及现金等价物净增加额-82,371,610.09-39,589,726.421,393,466.5792,615,142.85
  加:期初现金及现金等价物余额621,472,058.86621,472,058.86621,472,058.86528,856,916.01
  期末现金及现金等价物余额539,100,448.77581,882,332.44622,865,525.43621,472,058.86
补充资料:
  净利润-3,899,489.49--260,398,538.1
  资产减值准备---95,483,872.25
  固定资产和投资性房地产折旧-209,656,404.83-436,870,869.58
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-209,656,404.83-436,870,869.58
  无形资产摊销---40,731,784.01
  长期待摊费用摊销-3,400,419.19-5,840,120.71
  处置固定资产、无形资产和其他长期资产的损失--3,608.51--13,433,851.23
  固定资产报废损失-1,011,497.95-2,823,314
  公允价值变动损失-7,940,809.61-1,370.4
  财务费用-84,653,023.67-149,960,419.26
  投资损失--30,500,342.49-61,730,501.82
  递延所得税--9,218,335.72--52,606,012.36
  其中:递延所得税资产减少--8,879,495.97--50,558,128.34
    递延所得税负债增加--338,839.75--2,047,884.02
  存货的减少--48,414,097.08-175,919,720.41
  经营性应收项目的减少--1,525,805.28--85,358,560.11
  经营性应付项目的增加--87,340,683.6--3,471,739.46
  其他---174,981.28
  现金的期末余额-581,882,332.44-621,472,058.86
  减:现金的期初余额-621,472,058.86-528,856,916.01
  现金及现金等价物的净增加额--39,589,726.42-92,615,142.85
公告日期2026-10-232026-08-142026-04-242026-04-16
审计意见(境内)标准无保留意见
TOP↑